Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis - CMAJ | Journal
Sentiment Mix
Geography
Expert Signals
Politics - Google News CA Headlines
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Cardiovascular and renal outcomes of combined SGLT2 inhibitors and GLP-1 receptor agonists versus monotherapy in patients with type 2 diabetes mellitus: a network meta-analysis - CMAJ
Supported by 2 stories
Related Events
Iran war: Trump cancels envoys' trip to Islamabad - DW.com
Research • 7/13/2026
Chronic inflammation could be impacting your mental and cognitive health, research shows
Uncategorized • 7/13/2026
Jay-Z Yankee Stadium Review: Three Nights of Legacy and Guest Stars
Uncategorized • 7/13/2026
Waller says Fed shouldn't 'fight the last war' on inflation but warns hikes still possible - CNBC
Uncategorized • 7/14/2026
Médecins de famille en région | Le gouvernement Fréchette investit 2 millions dans le projet de l’Université du Québec
Uncategorized • 7/13/2026